Listed

TherapeuticsMD, Inc.: Form 10-Q for the period ended Mar 31, 2021

Filed with the SEC on May 6, 2021 and accepted by EDGAR at May 6, 2021, 16:56 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2021-01-01 to 2021-03-31$19.9mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2021-01-01 to 2021-03-31$4.7mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2021-01-01 to 2021-03-31$15.2mus-gaap:GrossProfit
Research and development3 months2021-01-01 to 2021-03-31$2.0mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2021-01-01 to 2021-03-31$42.4mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2021-01-01 to 2021-03-31−$29.3mus-gaap:OperatingIncomeLoss
Interest expense3 months2021-01-01 to 2021-03-31$10.2mus-gaap:InterestExpense
Income tax3 months2021-01-01 to 2021-03-31$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2021-01-01 to 2021-03-31−$39.4mus-gaap:NetIncomeLoss
Diluted EPS3 months2021-01-01 to 2021-03-31$0.11us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow3 months2021-01-01 to 2021-03-31−$38.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2021-01-01 to 2021-03-31$63.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2021-03-31$137.6mus-gaap:Cash
Current assetsAt period end2021-03-31$187.0mus-gaap:AssetsCurrent
Total assetsAt period end2021-03-31$239.3mus-gaap:Assets
Current liabilitiesAt period end2021-03-31$61.3mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2021-03-31$248.8mus-gaap:Liabilities
Long-term debtAt period end2021-03-31$179.0mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2021-03-31$5.0mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2021-03-31−$9.5mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001193125-21-153419. Last ingested by Listed: Nov 14, 2026, 19:24 ET. Listed shows no prices and gives no investment advice.